Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer ... (from Bloomberg.com court filings in that...)

Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer Litigation

Date:2/24/2013

from Bloomberg.com, court filings in that case show Takeda Pharmaceuticals secretly surveyed a dozen doctors in 2003 to see if they would use a diabetes drug with their patients that carried a warning about the potential for bladder cancer. Plaintiff’s attorneys assert the survey found that “a bladder cancer warning would destroy the sales of Takeda’s most important drug.”**(Cooper v. Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles))

After the FDA mandated the Actos label change in June 2011, a number of additional studies confirmed the link between long-term use of the drug and bladder cancer. Most recently, a study published in the British Diabetic Association journal, “Diabetic Medicine,” found that the risk of bladder cancer was significantly higher in patients using Actos compared with control groups.****

Actos users who developed bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing an Actos bladder cancer lawsuit by visiting Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com/. For additional information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.

*lawd.uscourts.gov/sites/default/files/UPLOADS/11-md-2299.021913.Scheduling.Order.PBP.pdf
** fda.gov/drugs/drugsafety/ucm259150.htm
***bloomberg.com/news/2013-02-15/takeda-worried-about-actos-s-cancer-link-filing-shows.html
**** ncbi.nlm.nih.gov/pubmed/23350856

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP

Post Your Comments:

(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd ... to gum disease and would like permanent tooth replacements now ... laser gum surgery. Gum disease must be treated ... out of all tooth replacement options. , The Laser ... cleared by the Food and Drug Administration (FDA) that greatly ...

(Date:5/21/2013)... practice transformation on a large scale is the ... at achieving better outcomes, better value and better ... toward the patient-centered medical home model offers a ... U.S. Department of Health and Human Services, Agency ... to learn more about the processes and determinants ...

(Date:5/21/2013)... Parker Waichman LLP, a national law ... by defective medical devices, is addressing new research published ... May 15, 2013. The study found that magnetic resonance ... occur in patients with metal-on-metal hip implants even before ... , “We’ve known for quite some ...

(Date:5/21/2013)... Beach, CA (PRWEB) May 21, 2013 ... 3rd Annual EB-5 Investment Summit: Dealmakers Conference in ... Dealmakers Conference will focus on exploring alternative finance ... provide the latest market, legal and economic information, ... immigration and legal professionals within the EB-5 industry. ...

(Date:5/21/2013)... 2013 Arizona State University is ... to develop their ideas into solutions, products and ... The university is recruiting participants for AREA48 (Applied ... that provides early-stage entrepreneurs with opportunities to access ... to anyone, ASU is particularly seeking participation from ...

Breaking Medicine News(10 mins):Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3 Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4

[0] Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA [0] AHRQ-funded journal supplement offers lessons on primary care practice transformation [0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants [0] Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California [0] ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors

... Pa., Sept. 14 Digestive Care, Inc. (DCI) announced today ... the U.S. Food and Drug Administration (FDA) and has moved ... for PANCRECARB((R) )(pancrelipase) used for the treatment of Exocrine Pancreatic ... working closely with the FDA throughout the NDA process and ...

... , BALTIMORE, Sept. 14 Care Improvement Plus, ... plans and a leader in improving the quality of care ... vice president of market growth and development. , ... responsible for the development of sales objectives and strategies to ...

... , PHILADELPHIA, Sept. 14 The ... class of RAPS Fellows. The 16 Fellows are highly ... They were honored during the opening session of the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO ...

... ALISO VIEJO, Calif., Sept. 14 Bausch & Lomb announces that ... U.S. media markets to educate baby boomers and seniors about ... , , Television advertising featuring Crystalens ... Albany, Rochester, Syracuse, and New York City. In addition, the ads ...

... , , INDIANAPOLIS, Sept. 14 ... a new operating model and announced a series of changes to ... goal, the company will establish a Development Center of Excellence to ... its pharmaceutical business into four business units that will operate alongside ...

... , , , ... and CCES Acknowledge NSF International,s Certified for Sport(TM) Certification as Important ... and EDMONTON, Alberta, Sept. 14 Afexa Life Sciences Inc. ("Afexa") ... in North America from the leading product safety and banned substances ...

Cached Medicine News:Health News:Digestive Care, Inc. Receives Complete Response Letter from FDA for PANCRECARB(R) (pancrelipase) 2 Health News:Care Improvement Plus Names Anthony Colistra as Vice President, Market Growth and Development 2 Health News:Regulatory Affairs Professionals Society (RAPS) Honors 2009 RAPS Fellows 2 Health News:Regulatory Affairs Professionals Society (RAPS) Honors 2009 RAPS Fellows 3 Health News:Bausch & Lomb's Crystalens(R) to be Featured in Direct-to-Consumer Advertising 2 Health News:Bausch & Lomb's Crystalens(R) to be Featured in Direct-to-Consumer Advertising 3 Health News:Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 2 Health News:Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 3 Health News:Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 4 Health News:Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 5 Health News:COLD-FX(R) Receives Highest Sports Certification in North America 2 Health News:COLD-FX(R) Receives Highest Sports Certification in North America 3 Health News:COLD-FX(R) Receives Highest Sports Certification in North America 4

Digestive Care, Inc. Receives Complete Response Letter from FDA for PANCRECARB(R) (pancrelipase)Care Improvement Plus Names Anthony Colistra as Vice President, Market Growth and Development Regulatory Affairs Professionals Society (RAPS) Honors 2009 RAPS Fellows Bausch & Lomb's Crystalens(R) to be Featured in Direct-to-Consumer Advertising Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients COLD-FX(R) Receives Highest Sports Certification in North America

(Date:5/21/2013)... , May 21, 2013 Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...

(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...

(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... study is to offer synopsis of the ...

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)

... 19, 2011 Varian Medical Systems, Inc., ... Inc., today announced they have signed a definitive agreement ... developer and supplier of specialized products and software for ... radiotherapy. The acquisition, which is anticipated to close in ...

... Sept. 19, 2011 VIDA Diagnostics, a leading developer ... company has achieved International Organization for Standardization (ISO 13485) ... The CE certification permits VIDA to sell Apollo for ... Switzerland. Apollo currently has FDA 510(k) approval for clinical ...

Cached Medicine Technology:Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 2 Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 3 Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 4 Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 5

Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy VIDA Diagnostics Earns ISO 13485 and CE Certifications

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Reducing Substances, Fecal RBC Fecal Rapid Plasma Reagin (RPR with Reflex to Fluorescent Treponemal Antibody, IgG Confirmation Rabies Antibody(Vaccine Response)